Seroprevalence of measles among children affected by national measles elimination program in Korea, 2010

Vaccine

Volumn 30, Issue 23, 2012, Pages 3355-3359

  Kim, Eun Seong ^a   Choe, Young June ^a   Cho, Heeyeon ^a,b   Kim, You Jin ^a   Yoon, Hee Sook ^a   Yang, Jeong Sun ^a   Kim, Kisoon ^a   Bae, Geun Ryang ^a   Lee, Duk hyoung ^a  

^a Korea Centers for Disease Control and Prevention   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Measles; Seroepidemiology; Seropositivity; Seroprevalence

Indexed keywords

IMMUNOGLOBULIN G; MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; CHILD; DISEASE CONTROL; DISEASE PREDISPOSITION; FEMALE; HEALTH PROGRAM; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MEASLES; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROPREVALENCE;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE ERADICATION; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MEASLES; MEASLES VACCINE; REPUBLIC OF KOREA; RISK ASSESSMENT; SEROEPIDEMIOLOGIC STUDIES;

EID: 84859840830     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.03.073     Document Type: Article

References (17)

1. Thacker S.B., Millar J.D. Mathematical modeling and attempts to eliminate measles: a tribute to the late Professor George Macdonald. Am J Epidemiol 1991, 133(March (6)):517-525.
2. King G.E., Markowitz L.E., Patriarca P.A., Dales L.G. Clinical efficacy of measles vaccine during the 1990 measles epidemic. Pediatr Infect Dis J 1991, 10(December (12)):883-888.
3. Watson J.C., Hadler S.C., Dykewicz C.A., Reef S., Phillips L. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1998, 47(May (RR-8)):1-57.
4. Peltola H., Jokinen S., Paunio M., Hovi T., Davidkin I. Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme. Lancet Infect Dis 2008, 8(December (12)):796-803.
5. Ramsay M.E., Jin L., White J., Litton P., Cohen B., Brown D. The elimination of indigenous measles transmission in England and Wales. J Infect Dis 2003, 187(May (Suppl. 1)):S198-S207.
6. Castillo-Solorzano C., Marsigli C., Danovaro-Holliday M.C., Ruiz-Matus C., Tambini G., Andrus J.K. Measles and rubella elimination initiatives in the Americas: lessons learned and best practices. J Infect Dis 2011, 204(July (Suppl. 1)):S279-S283.
7. Progress toward elimination of measles from the Americas. MMWR Morb Mortal Wkly Rep 1998 March 20;47(10):189-193.
8. Bae G.R., Lim H.S., Goh U.Y., Yang B.G., Kim Y.T., Lee J.K. Seroprevalence of measles antibody and its attributable factors in elementary students of routine 2-dose schedule era with vaccination record. J Prev Med Public Health 2005, 38(November (4)):431-436.
9. Elimination of measles-South Korea, 2001-2006. MMWR Morb Mortal Wkly Rep 2007 April 6;56(13):304-307.
10. So J.S., Go U.Y., Lee D.H., Park K.S., Lee J.K. Epidemiological investigation of a measles outbreak in a preschool in Incheon, Korea, 2006. J Prev Med Public Health 2008, 41(May (3)):153-158.
11. Choi W.S., Sniadack D.H., Jee Y., Go U.Y., So J.S., Cho H., et al. Outbreak of measles in the Republic of Korea, 2007: importance of nosocomial transmission. J Infect Dis 2011, 204(July (Suppl. 1)):S483-S490.
12. Kim S.S., Han H.W., Go U., Chung H.W. Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity. Vaccine 2004, 23(December (3)):290-297.
13. Lee K., Kim H., Shin E., Kim Y., Chang S., Choi J. Validity of measles immunization certificates submitted upon enrolment in an elementary school in Korea. J Prev Med Public Health 2009, 42(March (2)):104-108.
14. Fu C., Xu J., Liu W., Zhang W., Wang M., Nie J., et al. Low measles seropositivity rate among children and young adults: a sero-epidemiological study in southern China in 2008. Vaccine 2010, 28(November (51)):8219-8223.
15. Davidkin I., Jokinen S., Broman M., Leinikki P., Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis 2008, 197(April (7)):950-956.
16. Dai B., Chen Z.H., Liu Q.C., Wu T., Guo C.Y., Wang X.Z., et al. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China. Bull World Health Organ 1991, 69(4):415-423.
17. Cohen B.J., Doblas D., Andrews N. Comparison of plaque reduction neutralization test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination. Vaccine 2008, 26(November (50)):6392-6397.